The Broader Burden of Disease: Understanding Atopic and Non-Atopic Comorbidities

At AAD 2027 | Date: Thursday, March 18, 2027 | Time: 2:00 - 5:00 PM Pacific

Moscone Center | 747 Howard Steet  San Francisco, California 94103 USA | West Building - Level 2, Room 2002/2004

PROGRAM CO-CHAIRS 

Eric Simpson, MD MCR IEC Councilor Oregon Health & Sciences University Portland, Oregon, USA		Benjamin Ungar, MD IEC Councilor Mount Sinai Hospital New York, New York, USA

Session Description

Atopic dermatitis extends well beyond the skin, with a broad spectrum of atopic and non-atopic comorbidities that can significantly affect patient health and quality of life. This session will examine evolving evidence surrounding the atopic march; cardiovascular, metabolic, psychiatric, and mental health associations; the role of Staphylococcus aureus and the microbiome; and the clinical overlap between atopic dermatitis and cutaneous T-cell lymphoma. Participants will gain practical insights into recognizing these complex associations and considering how treatment decisions may influence comorbidity risk and overall patient outcomes.

Learning Objectives
At the conclusion of this symposium, participants will be able to:

1. Identify at least three atopic and non-atopic comorbidities associated with atopic dermatitis.
2. Describe two ways that atopic dermatitis treatment may influence comorbidity risk and patient outcomes.
3. Apply key clinical findings to differentiate common atopic dermatitis comorbidities from conditions requiring further evaluation.

AGENDA

2 – 2:10 PM Welcome from the IEC
Alan Irvine, MD DSc | IEC President | Trinity College Dublin, Children’s Health | Dublin, Ireland

2:10 – 2:35 PM The Atopic March & Epidemiology: Latest perils and pitfalls and how to march forward
Speaker TBA

2:35 – 3:05 PM Cardiovascular & Metabolic Associations with AD: Can treating the disease prevent the comorbidity?
April W. Armstrong, MD MPH | IEC Director | University of California Los Angeles 

3:05 – 3:35 PM Moderated Discussion Panel • Psychiatric and Mental Health Barriers: What are you hearing from your patients? Can expert recommendations be part of the problem?
Speakers TBA
(Moderated by Drs. Eric Simpson and Benji Ungar)

3:35 – 3:45 PM BREAK & NETWORKING

3:45 – 4:15 PM Staphylococcus aureus – A Cause or Consequence in AD? Is therapeutic manipulation of the microbiome effective?
Tissa Hata, MD | UCSD Dermatology Clinical Trials Unit, UCSD Department of Dermatology San Diego, CA

4:15 - 4:45 PM AD & CTCL: Mechanisms and Myths 
Speaker TBA

4:45 - 5 PM Closing Remarks, Session Evaluation, Final Networking & Adjourn

Please check back with us for updates.

This educational symposium presented by the IEC is offered at no cost to attendees.